menu
    • menu
    [{"orgOrder":0,"company":"Enable Injections","sponsor":"Incyte Corporation","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"U.S.A","productType":"Antibody, Unconjugated","year":"2025","type":"Collaboration","leadProduct":"INCA033989","moa":"CALR","graph1":"Hematology","graph2":"Phase I","graph3":"Enable Injections","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Enable Injections \/ Incyte Corporation","highestDevelopmentStatusID":"6","companyTruncated":"Enable Injections \/ Incyte Corporation"}]

    Find Clinical Drug Pipeline Developments & Deals by Enable Injections

    Menu

    Enable Injections

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Enable Injections

                            U.S.A arrow
                            Tides Europe
                            Not Confirmed

                            Enable Injections

                            U.S.A arrow
                            Tides Europe
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : INCA033989

                            Therapeutic Area : Hematology

                            Study Phase : Phase I

                            Sponsor : Incyte Corporation

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            Incyte, Enable Injections Partner for enFuse On-Body Delivery System

                            Details : The collaboration aims to advance the clinical development of INCA033989, an unconjugated antibody targeting CALR, for essential thrombocythemia (ET).

                            Product Name : Undisclosed

                            Product Type : Antibody, Unconjugated

                            Upfront Cash : Undisclosed

                            October 27, 2025

                            Lead Product(s) : INCA033989

                            Therapeutic Area : Hematology

                            Highest Development Status : Phase I

                            Sponsor : Incyte Corporation

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth